China - White Paper- CFR of 5.6% and Vaccine should be available early next year.

[kiwibird]

http://www.mychinanews.com/news/n/5/2470718

“White Paper” with a per capita cost of 23,000 yuan shows that as of 24:00 on May 31, 2020, the cure rate of new coronary pneumonia was 94.3%, and the mortality rate was 5.6%.
....
A few days ago, the State-owned Assets Supervision and Administration Commission announced that according to the Beijing Institute of Biological Products, from May 30th, the new crown inactivated vaccine production workshop will officially enter the final preparation before production after full disinfection. The vaccine will be available at the end of this year or early next year.

Vaccine expert Tao Lina told reporters from Beijing Business Daily that China is still in a leading position in the research and development of new crown vaccines, and China is carrying out multiple technical routes such as adenovirus vector vaccine and inactivated vaccine simultaneously, which can be said to be double insurance. However, he also emphasized that there are still some difficulties to be overcome in the follow-up development of vaccines, and there are still unpredictable places.
​​​​​​​

http://www.mychinanews.com/news/n/5/2470718